---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-148114"
form_type: "8-K"
ticker: "HOWL"
cik: "0001785530"
company_name: "Werewolf Therapeutics, Inc."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:09:06.033798+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Werewolf Therapeutics shareholders elect three Class III directors, ratify EY auditor

## Summary
- Elected Michael Atkins, Luke Evnin, and Alon Lazarus as Class III directors; Atkins 31.6M votes for, Evnin 20.7M, Lazarus 31.5M.
- Broker non-votes of 5.1M shares on each director election.
- Ratified Ernst & Young as independent auditor for FY2024: 36.7M for, 41.9K against, 2.9K abstain.

## SEC filing metadata
- accession: 0001193125-24-148114
- form_type: 8-K
- ticker: HOWL
- cik: 0001785530
- company_name: Werewolf Therapeutics, Inc.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785530/000119312524148114/0001193125-24-148114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785530/000119312524148114/d794252d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-148114
- JSON: https://secwatch.observer/filing/0001193125-24-148114.json
- Plain text: https://secwatch.observer/filing/0001193125-24-148114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.